Evidence map›Paper›PMID 33069489›Full record

Observational studyActas urologicas espanolas2020

Urological surgery during SARS-CoV-2 pandemic. Descriptive analysis of the experience in a Urology Department across the pandemic phases.

A González-Díaz, P Abad-López, E Peña-Vallejo, M P Caro-González, C Calzas-Montalvo, J Gil-Moradillo, N Miranda-Utrera, J Díez-Sebastián, C Varela-Rodríguez, A Rodríguez-Antolín and 1 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Actas urologicas espanolas, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

A González-DíazServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España. Electronic address: alejandroglezdiaz@gmail.com.
P Abad-LópezServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
E Peña-VallejoServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
M P Caro-GonzálezServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
C Calzas-MontalvoServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
J Gil-MoradilloServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
N Miranda-UtreraServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
J Díez-SebastiánServicio de Medicina Preventiva y Salud Pública, Hospital Universitario La Paz, Madrid, España.
C Varela-RodríguezUnidad de Calidad Asistencial, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
A Rodríguez-AntolínServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
A Tejido-SánchezServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre i+12 (imas12), Madrid, España.
Hospital Universitario 12 De Octubre · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe SARS-CoV-2 pandemic has changed the urological practice around the world. Our objective is to describe the outcomes presented by patients undergoing surgery in the urology department of a tertiary hospital, across the pandemic phases.

methodsObservational, cohort study including all patients undergoing surgery from March 1 to May 14. According to the hospital organization, we identified three periods: there were no changes during the first two weeks (1

results103 urological surgeries were performed, and 11 patients were diagnosed with COVID-19, 8 of them within the 1 PERIOD: The diagnosis was already known in 1 patient, while the other 10 developed the disease in an average of 25 days after the intervention and 16,6 days after discharge. Of seven transplant patients, four got the infection. Three deaths were recorded due to the disease: a 69-year-old woman transplanted and two men over 80 with comorbidities and high anesthetic risk who underwent drainage of retroperitoneal abscess and retrograde intrarenal surgery, respectively.

conclusionsSARS-CoV-2 infection mainly affected renal transplant recipients or elderly patients with high anesthetic risk, during the first 2 weeks of the pandemic. After implementing preoperative PCR tests and a comprehensive screening protocol, cases were substantially reduced, and safe surgical procedures were achieved.

Indexed as

PandemicsSARS-CoV-2AgedAged, 80 and overCohort StudiesCOVID-19Elective Surgical ProceduresFemaleHumansKidney TransplantationMaleMiddle AgedProspective StudiesRetrospective StudiesSpainSymptom AssessmentCirugíaCOVID-19Infección postoperatoriaKidney transplantationPostoperative infectionProtocolo de cribadoSARS-CoV-2Screening protocolSurgeryTrasplante renal

Identifiers

PMID33069489
PMCPMC7522646
OpenAlexW3088892228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.